Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David S. Kabakoff
AddedMar 31, 2024
UpdatedMay 31, 2026
David S. Kabakoff

David S. Kabakoff

Board Member, NextCure

Crunchbase

David S. Kabakoff's Career

NextCure
NextCure

Beltsville, MD, US

Board Member· Board
Castle Biosciences
Castle Biosciences

Friendswood, TX, US

Board Member· Board
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals

San Diego, CA, US

Board Member· Board
Neurana Pharmaceuticals
Neurana Pharmaceuticals

San Diego, CA, US

Board Member· Board
Rainier Therapeutics
Rainier Therapeutics

San Leandro, CA, US

Board Member· Board
Antiva Biosciences
Antiva Biosciences

South San Francisco, CA, US

Board Member· Board
RareCyte
RareCyte

Seattle, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David S. Kabakoff's Career

NextCure
NextCure
Public$310M902015Beltsville, MD, US
Board Member· Board

Leadership at NextCure

Garry NicholsonGarry NicholsonBoard Member
John HoustonJohn HoustonBoard Member
Judith LiJudith LiBoard Member
Michael RichmanMichael RichmanBoard Member
Michael RichmanMichael RichmanCo-Founder
Stephen WebsterStephen WebsterBoard Member
Castle Biosciences
Castle Biosciences
Public$354.3M5432008Friendswood, TX, US
Board Member· Board

Leadership at Castle Biosciences

G. Bradley ColeG. Bradley ColeBoard Member
Tiffany OlsonTiffany OlsonBoard Member
Mara AspinallMara AspinallBoard Member
Garheng KongGarheng KongBoard Member
Mr. Derek J. MaetzoldMr. Derek J. MaetzoldFounder
Dan BradburyDan BradburyBoard Member

Similar to Castle Biosciences

Predictive BiosciencesPredictive BiosciencesLexington, KY, USCancer Testsest. 2006Predictive BiosciencesLexington, KY, US · est. 2006

Predictive Biosciences develops molecular tests and technologies for cancer diagnosis and monitoring in the US.

Pre-Seed · $68.1M75
BiodesixBiodesixBoulder, CO, USDiagnostic Testsest. 2005BiodesixBoulder, CO, US · est. 2005

Biodesix, Inc.: A leading biotech firm providing data-driven diagnostic solutions and lab tests in the US.

Public · $390.3M245
Caris Life SciencesCaris Life SciencesIrving, TX, USCancer Diagnosticsest. 1996Caris Life SciencesIrving, TX, US · est. 1996

US-based Caris Life Sciences specializes in innovative biotech solutions for cancer diagnosis and treatment.

Public · $1.7B1.5k
Foundation MedicineFoundation MedicineCambridge, MA, USCancer Diagnosticsest. 2010Foundation MedicineCambridge, MA, US · est. 2010

Foundation Medicine, Inc.: A U.S. genomics firm specializing in personalized cancer diagnostic technology.

Public · $96.5M662
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals
Series A$40M112015San Diego, CA, US
Board Member· Board

Leadership at Dauntless Pharmaceuticals

Mike PowellMike PowellBoard Member
Nina KjellsonNina KjellsonBoard Member
Joel MartinJoel MartinFounder

Similar to Dauntless Pharmaceuticals

Manhattan PharmaceuticalsManhattan PharmaceuticalsNew York City, NY, USHealthcare Productsest. 2003Manhattan PharmaceuticalsNew York City, NY, US · est. 2003

Manhattan Pharmaceuticals: Innovating specialty healthcare treatments for underserved populations.

Public · $2.5M4
Concours PharmaceuticalsConcours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30
Saptalis PharmaceuticalsSaptalis PharmaceuticalsHauppauge, NY, USGenerics, Pharmaceuticalsest. 2015Saptalis PharmaceuticalsHauppauge, NY, US · est. 2015

Saptalis Pharmaceuticals: Innovating complex generic drugs and challenging dosage forms.

Public · $9.5M33
Dose TherapeuticsDose TherapeuticsDallas, TX, USMedicinesest. 2021Dose TherapeuticsDallas, TX, US · est. 2021

Dose Therapeutics: A biotech firm innovating advanced medicines for unmet medical needs.

Series A · $10M5
Neurana Pharmaceuticals
Neurana Pharmaceuticals
Series A$60M52013San Diego, CA, US
Board Member· Board

Leadership at Neurana Pharmaceuticals

David F. HaleDavid F. HaleBoard Member
Alex ZissonAlex ZissonBoard Member
Judy CaronJudy CaronFounder
J Craig ThompsonJ Craig ThompsonCEO
Rainier Therapeutics
Rainier Therapeutics
Series B$89M312010San Leandro, CA, US
Board Member· Board

Leadership at Rainier Therapeutics

Joël Jean-MairetJoël Jean-MairetBoard Member
Marten SteenMarten SteenBoard Member
Stephen LauStephen LauFounder
Scott MyersScott MyersBoard Member
Dr Gorjan Hrustanovic PhDDr Gorjan Hrustanovic PhDBoard Member
Antiva Biosciences
Antiva Biosciences
Series E$140.3M242012South San Francisco, CA, US
Board Member· Board

Leadership at Antiva Biosciences

Steven JamesSteven JamesBoard Member
Gail MaderisGail MaderisBoard Member
Jenny YipJenny YipBoard Member
Wende HuttonWende HuttonBoard Member
Kristine BallKristine BallBoard Member
Vinzenz PloererVinzenz PloererBoard Member
RareCyte
RareCyte
Public$76M782009Seattle, WA, US
Board Member· Board

Leadership at RareCyte

Andy SchwabAndy SchwabBoard Member
Brian DanielsBrian DanielsBoard Member
Frank WitneyFrank WitneyBoard Member
Jan GarfinkleJan GarfinkleBoard Member
Daniel R. MarshakDaniel R. MarshakBoard Member
Joseph VictorJoseph VictorBoard Member

David S. Kabakoff's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to David S. Kabakoff

Antony ResslerAntony ResslerBoard Member · Cedars-SinaiJens WeitzelJens WeitzelBoard Member · StartXDavid A. SteinbergDavid A. SteinbergBoard Member · Core Capital PartnersDan FeshbachDan FeshbachCo-Founder · Animated SpeechDavid BlockDavid BlockCEO · GliknikJay YuJay YuBoard Member · Test Diagnostics